Found: 61
Select item for more details and to access through your institution.
Real-time HER2 status detected on circulating tumor cells predicts different outcomes of anti-HER2 therapy in histologically HER2-positive metastatic breast cancer patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China.
- Published in:
- Cancer Biology & Medicine, 2024, v. 21, n. 10, p. 838, doi. 10.20892/j.issn.2095-3941.2024.0374
- By:
- Publication type:
- Article
Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1356825
- By:
- Publication type:
- Article
Corrigendum: Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1503195
- By:
- Publication type:
- Article
Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1356825
- By:
- Publication type:
- Article
tRNA-Derived Fragments as Novel Predictive Biomarkers for Trastuzumab-Resistant Breast Cancer.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 49, n. 2, p. 419, doi. 10.1159/000492977
- By:
- Publication type:
- Article
A randomized phase 3 trial of Gemcitabine or Nab-paclitaxel combined with cisPlatin as first-line treatment in patients with metastatic triple-negative breast cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31704-7
- By:
- Publication type:
- Article
Mobilization of Peripheral Blood Stem Cells with High Dose Cyclophosphamide Combination Chemotherapy and G-CSF in Breast Cancer Patients.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2000, v. 8, n. 4, p. 295
- By:
- Publication type:
- Article
Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 200, n. 2, p. 281, doi. 10.1007/s10549-023-06972-6
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy for strongly hormone receptor-positive and HER2-negative early breast cancer: results of a prospective multi-center study.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 195, n. 3, p. 301, doi. 10.1007/s10549-022-06686-1
- By:
- Publication type:
- Article
Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-22913-7
- By:
- Publication type:
- Article
Electroacupuncture for post-stroke urinary incontinence: a systematic review and meta-analysis with trial sequential analysis.
- Published in:
- Frontiers in Neurology, 2023, p. 1, doi. 10.3389/fneur.2023.1282580
- By:
- Publication type:
- Article
CSCO breast cancer guideline: precise, economical and oriental.
- Published in:
- SCIENCE CHINA Life Sciences, 2020, v. 63, n. 9, p. 1, doi. 10.1007/s11427-020-1701-5
- By:
- Publication type:
- Article
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2−, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241286775
- By:
- Publication type:
- Article
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03468-5
- By:
- Publication type:
- Article
De-escalation of neoadjuvant taxane and carboplatin therapy in HER2-positive breast cancer with dual HER2 blockade: a multicenter real-world experience in China.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03468-5
- By:
- Publication type:
- Article
Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2010, v. 6, n. 4, p. 320, doi. 10.1111/j.1743-7563.2010.01323.x
- By:
- Publication type:
- Article
Superior efficacy of a Cremophor-free albumin-bound paclitaxel compared with solvent-based paclitaxel in Chinese patients with metastatic breast cancer.
- Published in:
- Asia Pacific Journal of Clinical Oncology, 2009, v. 5, n. 3, p. 165, doi. 10.1111/j.1743-7563.2009.01235.x
- By:
- Publication type:
- Article
Bone metabolism markers: Indicators of loading dose intravenous ibandronate treatment for bone metastases from breast cancer.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 1, p. 88, doi. 10.1111/1440-1681.12673
- By:
- Publication type:
- Article
Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45591-7
- By:
- Publication type:
- Article
Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211013326
- By:
- Publication type:
- Article
Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211013326
- By:
- Publication type:
- Article
Effective modulation of CD4CD25 regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2357, doi. 10.1007/s00262-012-1297-2
- By:
- Publication type:
- Article
Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02708-3
- By:
- Publication type:
- Article
Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 6, p. e2321388, doi. 10.1001/jamanetworkopen.2023.21388
- By:
- Publication type:
- Article
Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 19, p. 6744, doi. 10.1002/cam4.4215
- By:
- Publication type:
- Article
Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.606477
- By:
- Publication type:
- Article
Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.599604
- By:
- Publication type:
- Article
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2 positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 4, p. 1, doi. 10.1186/s13058-014-0405-y
- By:
- Publication type:
- Article
Association of phosphatase and tensin homolog low and phosphatidylinositol 3-kinase catalytic subunit alpha gene mutations on outcome in human epidermal growth factor receptor 2-positive metastatic breast cancer patients treated with first-line lapatinib plus paclitaxel or paclitaxel alone.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Hot issues in triple-negative breast cancer.
- Published in:
- Cancer Biology & Medicine, 2023, v. 20, n. 12, p. 981, doi. 10.20892/j.issn.2095-3941.2023.0294
- By:
- Publication type:
- Article
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 6, p. 769, doi. 10.20892/j.issn.2095-3941.2022.0277
- By:
- Publication type:
- Article
Conversion of ER, PR, HER2 and Ki-67 and Prognosis in breast cancer metastases to the brain.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.1002173
- By:
- Publication type:
- Article
Oral vinorelbine versus intravenous vinorelbine, in combination with epirubicin as first-line chemotherapy in Chinese patients with metastatic breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effect of ethnicity on vinorelbine pharmacokinetics: a population pharmacokinetics analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Fulvestrant 250 mg versus anastrozole for Chinese patients with advanced breast cancer: results of a multicentre, double-blind, randomised phase III trial.
- Published in:
- 2011
- By:
- Publication type:
- Report
Key clinical studies on changing clinical practice of advanced breast cancer in 2022.
- Published in:
- China Oncology, 2023, v. 33, n. 2, p. 110, doi. 10.19401/j.cnki.1007-3639.2023.02.003
- By:
- Publication type:
- Article
Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 8, p. 1961, doi. 10.1002/ijc.28829
- By:
- Publication type:
- Article
A novel chemical inhibitor suppresses breast cancer cell growth and metastasis through inhibiting HPIP oncoprotein.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00580-3
- By:
- Publication type:
- Article
Stellate ganglion, inflammation, and arrhythmias: a new perspective on neuroimmune regulation.
- Published in:
- Frontiers in Cardiovascular Medicine, 2024, p. 01, doi. 10.3389/fcvm.2024.1453127
- By:
- Publication type:
- Article
Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers.
- Published in:
- Human Mutation, 2005, v. 26, n. 4, p. 303, doi. 10.1002/humu.20232
- By:
- Publication type:
- Article
Author Correction: Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Phase III study of HR-positive/HER2-negative/lymph node-positive breast cancer non-responsive to primary chemotherapy: a randomized trial.
- Published in:
- NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00553-y
- By:
- Publication type:
- Article
Identification of oxidative stress-related diagnostic markers and immune infiltration features for idiopathic pulmonary fibrosis by bibliometrics and bioinformatics.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1356825
- By:
- Publication type:
- Article
Novel Anti-HER2 Antibody-Drug Conjugates Versus T-DM1 for HER2-Positive Metastatic Breast Cancer After Tyrosine Kinase Inhibitors Treatment.
- Published in:
- Oncologist, 2023, v. 28, n. 10, p. e859, doi. 10.1093/oncolo/oyad127
- By:
- Publication type:
- Article
Adjuvant Abemaciclib Combined with Endocrine Therapy: Efficacy Results in monarchE Cohort 1.
- Published in:
- Oncologist, 2023, v. 28, n. 1, p. e77, doi. 10.1093/oncolo/oyac234
- By:
- Publication type:
- Article
Prognostic Value of Modified IHC4 Score in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1170, doi. 10.1634/theoncologist.2019-1006
- By:
- Publication type:
- Article